Exploring the Global Genomic Landscape of Enteric Pathogens using DNA Microarray Technology
Dr Scott Jackson, Molecular Biologist, FDA, speaking at Advances in Microarray Technology 2012. Date Posted: Wednesday, November 21, 2012
Confusion as FDA Classify Genome Interpretation as Medical Test FDA conclude deciphering your genome should therefore be subject to approval by the appropriate regulatory bodies Monday, November 28, 2011FDA Announces New Warning on Plavix: Avoid Use with Prilosec/Prilosec OTC Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17.
New data suggest that when patients take both Prilosec and Plavix, Plavix’s ability to block platelet aggregation (anti-clotting effect) may be reduced by about half.
“Both of these drugs, when used properly, provide significant benefits to patients.” said Mary Ross Southworth, Pharm.D., of the Div Wednesday, November 25, 2009